IOVA ▲ +2.0% - Iovance Biotherapeutics, Inc. $IOVA - Iovance Announces Data Showing Durable Responses with Lifileucel TIL Cell Therapy in Advanced Soft Tissue Sarcomas at ESMO 2026 26-OCT-2026 07:00 AM ET